搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
11 小时
Climbing car sales, more repos: What's driving our 'wacky' auto economy
Cars have long been a key component of the American economy, and the current state of the auto market reflects a series of ...
14 小时
Auto-Owners car insurance review 2024: Affordable rates and extensive coverage options
Combining affordable rates and a variety of coverage options, Auto-Owners is one of our top picks for car insurance ...
2 天
Car insurance lapse: What is it, and what does it mean?
Understand the implications of a car insurance lapse, how it affects your record and what you can do to avoid it.
14 小时
Car Was Fine, But Hertz Rental Was Confusing
A Kia Soul rented from Hertz at New York’s JFK International Airport drove flawlessly, but instructions about paying for ...
1 天
Check If Your Child’s Car Seat Is Installed Properly For Free September 21
On National Seat Check Saturday, certified child passenger safety technicians will be available at car seat check stations ...
10 小时
Biden Administration to Prepare Ban on Chinese Car Software
The US Commerce Department is planning to reveal proposed rules that would ban Chinese- and Russian-made hardware and ...
3 天
复星医药达成双特异性CAR-T细胞治疗药物开发合作
集萃细胞所开发的基于双特异性CAR-T细胞治疗药物在血液肿瘤及自身免疫性系统疾病领域取得显著临床疗效,此次携手复星医药共同开展该管线的产业化及全球商业化,致力于打造江苏产研院/国创中心细胞治疗药物的重磅标志性成果,惠及更多患者。
12 天
肿瘤患者福音!河南自主研发抗癌新药-CAR-NK 全球首例输注
“您放轻松,基本上1个小时就能完成注射,和平时输液一样……”2024年9月9日10时37分,在河南省肿瘤医院肿瘤内科三病区病房里,“CAR-NK”细胞被缓缓输注52岁肺鳞癌患者李女士体内……至此,由河南省医学科学院肿瘤研究所副所长、河南省肿瘤医院内科 ...
8 天
全国首张CAR-T治疗处方开具,套细胞淋巴瘤迎来治疗新希望
在中国,癌症的治疗始终是一个备受关注的话题,特别是面对复发性或难治性肿瘤时,患者及其家庭更加渴望能有有效的治疗方案。近日,在广东省人民医院,李文瑜教授为一位七十多岁的套细胞淋巴瘤(MCL)患者开出了全国首张瑞基奥仑赛注射液(商品名:倍诺达®)处方,标 ...
WYFF on MSN
6 小时
One hurt after being shot in a car in Greenville County
Greenville police say that one person was found shot in a car at an apartment complex. Officers say it happened at 6:30 p.m.
2 天
复星医药全资控股复星凯特,加码细胞治疗能否推动CAR-T产品放量?
复星凯特董事长张文杰在接受21世纪经济报道记者采访时表示,复星医药正专注于医药领域中具有广阔前景的细分市场,包括小分子药物、抗体药物和细胞治疗。复星凯特在细胞治疗领域处于领先地位,而细胞治疗作为一种新兴的治疗方式,与传统药物模式有着本质的不同。过去,在肿瘤治疗领域,无论取得了多大的进展,最终目标都是延长患者的生存期并保持临床治愈,而细胞治疗的潜力在于它能够提供更为根本的治疗方案。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈